Medline Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: —
EBITDA: —
EBIT: —
EPS: —
Free cash flow: —
Operating cash flow: —

Forward estimates

Revenue: +9.1%
EBITDA: +27.8%
EPS: +31.3%

Three-year CAGR

Revenue: +9.9%
EBITDA: +1.7%
EBIT: +36.5%
Net income: +122.6%
EPS: +118.3%
Free cash flow: -3.7%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.